Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning ...

With that in mind, let's consider two stocks that people in their 30s -- who are still a good distance away from retirement - ...

Moderna ( ($MRNA) ) has risen by 10.01%. Read on to learn why. Moderna’s stock has experienced a notable increase of 10.01% over the past week, ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The average short interest in the S&P 500 Health Care Index Sector (XLV) dipped slightly in July to 1.95% from 1.96% in June.

The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children ...

Enphase Energy (ENPH) retained its spot as the most shorted S&P 500 (SP500) stock as a percentage of float in July, followed ...

Organizations are slowly merging HR and IT departments to create a unified approach to the workforce and the technology that ...

The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy ...

Shares of the biotech Moderna were up on Wednesday, as the Trump administration’s shifting position on messenger RNA-based ...

The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy children under 5 years old, the company confirmed Wednesday.  The move ...

Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...